2024 Q2 Form 10-Q Financial Statement

#000178217024000122 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $306.4M $269.1M $264.8M
YoY Change 30.93% 32.01% 38.59%
Cost Of Revenue $107.8M $89.88M $89.12M
YoY Change 34.41% 21.35% 24.01%
Gross Profit $198.6M $179.2M $175.6M
YoY Change 29.12% 38.09% 47.39%
Gross Profit Margin 64.83% 66.6% 66.34%
Selling, General & Admin $142.9M $132.3M $143.9M
YoY Change 24.76% 25.45% 47.92%
% of Gross Profit 71.96% 73.82% 81.94%
Research & Development $67.55M $63.21M $59.24M
YoY Change 24.39% 28.01% 38.14%
% of Gross Profit 34.01% 35.26% 33.73%
Depreciation & Amortization $3.907M $3.678M $3.488M
YoY Change 22.59% 21.43% 88.13%
% of Gross Profit 1.97% 2.05% 1.99%
Operating Expenses $67.55M $63.21M $206.6M
YoY Change -60.74% 28.01% 45.49%
Operating Profit -$15.76M -$19.95M -$31.00M
YoY Change -13.5% -28.91% 35.56%
Interest Expense $745.0K $769.0K $1.461M
YoY Change -3.99% 97.69% -24.96%
% of Operating Profit
Other Income/Expense, Net $5.764M -$1.586M -$64.00K
YoY Change -472.83% 4.96% -105.86%
Pretax Income -$8.801M -$20.08M -$29.60M
YoY Change -53.66% -28.13% 49.3%
Income Tax $3.290M $998.0K $5.417M
% Of Pretax Income
Net Earnings -$12.09M -$21.08M -$35.02M
YoY Change -35.86% -25.55% 80.57%
Net Earnings / Revenue -3.95% -7.83% -13.23%
Basic Earnings Per Share -$0.06 -$0.11
Diluted Earnings Per Share -$0.06 -$0.11 -$0.19
COMMON SHARES
Basic Shares Outstanding 192.5M shares 188.5M shares 185.2M shares
Diluted Shares Outstanding 193.5M shares 189.8M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $335.9M $488.0M $519.6M
YoY Change -34.07% 7.88% 13.27%
Cash & Equivalents $185.2M $286.0M $323.7M
Short-Term Investments
Other Short-Term Assets $1.782M $1.160M $1.317M
YoY Change -94.22% -96.3% -93.19%
Inventory
Prepaid Expenses $16.94M $22.73M $11.12M
Receivables
Other Receivables $2.908M $4.025M $0.00
Total Short-Term Assets $840.6M $972.0M $932.1M
YoY Change 23.76% 60.15% 39.24%
LONG-TERM ASSETS
Property, Plant & Equipment $22.18M $19.34M $16.01M
YoY Change -11.63% 52.75% 38.66%
Goodwill $54.94M $54.94M $54.94M
YoY Change 0.0% -0.09%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.404M $7.173M $7.071M
YoY Change 2.41% 4.52% 13.79%
Total Long-Term Assets $109.6M $107.2M $104.2M
YoY Change 4.06% -0.98% 292.66%
TOTAL ASSETS
Total Short-Term Assets $840.6M $972.0M $932.1M
Total Long-Term Assets $109.6M $107.2M $104.2M
Total Assets $950.2M $1.079B $1.036B
YoY Change 21.12% 50.9% 48.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.93M $12.28M $35.05M
YoY Change 18.84% 322.07% 415.91%
Accrued Expenses $145.5M $155.1M $145.8M
YoY Change 39.38% 95.12% 66.15%
Deferred Revenue
YoY Change
Short-Term Debt $2.394M $2.445M $2.481M
YoY Change -1.56% -1.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $341.8M $367.8M $366.8M
YoY Change 50.82% 86.28% 75.4%
LONG-TERM LIABILITIES
Long-Term Debt $15.00M $150.0M $130.0M
YoY Change -55.88%
Other Long-Term Liabilities $8.256M $6.653M $5.653M
YoY Change 1.5% -51.2% 438.38%
Total Long-Term Liabilities $23.26M $156.7M $135.7M
YoY Change -44.8% 1049.16% 12819.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $341.8M $367.8M $366.8M
Total Long-Term Liabilities $23.26M $156.7M $135.7M
Total Liabilities $371.3M $529.8M $507.0M
YoY Change 38.13% 141.1% 134.85%
SHAREHOLDERS EQUITY
Retained Earnings -$524.5M -$512.4M -$491.3M
YoY Change 24.69% 27.53% 31.55%
Common Stock $20.00K $19.00K $19.00K
YoY Change 11.11% 5.56% 11.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $578.9M $549.4M $529.3M
YoY Change
Total Liabilities & Shareholders Equity $950.2M $1.079B $1.036B
YoY Change 21.12% 50.9% 48.9%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$12.09M -$21.08M -$35.02M
YoY Change -35.86% -25.55% 80.57%
Depreciation, Depletion And Amortization $3.907M $3.678M $3.488M
YoY Change 22.59% 21.43% 88.13%
Cash From Operating Activities $48.90M -$56.81M -$34.47M
YoY Change -194.22% -13219.63% -55.44%
INVESTING ACTIVITIES
Capital Expenditures $4.256M $945.0K $2.584M
YoY Change 143.2% 9.38% 6.78%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $0.00 -$3.000K
YoY Change -100.0% -102.36%
Cash From Investing Activities -$4.256M -$4.314M -$2.587M
YoY Change 143.2% -89.99% 12.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -144.8M $26.12M 136.2M
YoY Change -493.44% -291.55% 4626.48%
NET CHANGE
Cash From Operating Activities 48.90M -$56.81M -34.47M
Cash From Investing Activities -4.256M -$4.314M -2.587M
Cash From Financing Activities -144.8M $26.12M 136.2M
Net Change In Cash -100.1M -$36.10M 99.11M
YoY Change 493.8% -35.63% -229.12%
FREE CASH FLOW
Cash From Operating Activities $48.90M -$56.81M -$34.47M
Capital Expenditures $4.256M $945.0K $2.584M
Free Cash Flow $44.64M -$57.75M -$37.05M
YoY Change -183.21% 13299.77% -53.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
68014000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
44123000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63206000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49376000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44173000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41408000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3678000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3029000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
289071000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
231933000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19953000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28068000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2226000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2024000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
769000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
389000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1586000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1511000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20082000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27944000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
998000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
370000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21080000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189848799 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189848799 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175113904 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175113904 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21080000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-642000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
348000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21722000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27966000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
529337000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5004000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2530000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1366000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35575000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-642000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21080000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
549358000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480087000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2729000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4993000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6635000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
581000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1413000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29775000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
348000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
495421000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21080000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3678000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3029000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
34088000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29234000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-249000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1083000 usd
CY2024Q1 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
6194000 usd
CY2023Q1 rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
44157000 usd
CY2024Q1 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
59432000 usd
CY2023Q1 rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
-69608000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10377000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12078000 usd
CY2024Q1 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1392000 usd
CY2023Q1 rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1184000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22707000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4512000 usd
CY2024Q1 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
14744000 usd
CY2023Q1 rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
-7448000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10429000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9570000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1598000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-355000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56808000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2296000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
945000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
864000 usd
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
3369000 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
1296000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
40933000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4314000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43093000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2483000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4844000 usd
CY2024Q1 rely Proceeds From Issuance Of Common Stock Espp
ProceedsFromIssuanceOfCommonStockESPP
5004000 usd
CY2023Q1 rely Proceeds From Issuance Of Common Stock Espp
ProceedsFromIssuanceOfCommonStockESPP
2729000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
275000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
75000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
255000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
75000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1366000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1413000 usd
CY2024Q1 us-gaap Repayments Of Assumed Debt
RepaymentsOfAssumedDebt
0 usd
CY2023Q1 us-gaap Repayments Of Assumed Debt
RepaymentsOfAssumedDebt
17068000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26121000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10908000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1099000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36100000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56078000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325029000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300735000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288929000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244657000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285997000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244159000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2190000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
444000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
742000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
54000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
288929000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244657000 usd
CY2024Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
170 country
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes have been prepared consistently, with the exception of certain prior year amounts which have been reclassified to conform with the current period presentation. Reclassifications include a change in presentation of shares purchased under the ESPP within the Company’s Condensed Consolidated Statements of Cash Flows. Beginning in the year ended December 31, 2023, the Company changed the presentation of shares purchased under the ESPP to reflect an operating cash outflow for compensation paid to employees and a financing cash inflow for cash paid by employees in exchange for shares. Previously, such activity was treated and disclosed as noncash activity for the three months ended March 31, 2023. The Company has conformed the prior period statement of cash flows to the current period presentation to enhance transparency and provide comparability.</span></div>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates </span></div>The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed within the condensed consolidated financial statements and accompanying notes. These estimates and assumptions include, but are not limited to, revenue recognition including the treatment of sales incentive programs, reserves for transaction losses, stock-based compensation expense, the carrying value of operating lease right-of-use assets, the recoverability of deferred tax assets, capitalization of software development costs, goodwill, and the recoverability of intangible assets. The key assumptions applied for value of the intangible assets include revenue growth rates for a hypothetical market participant, selected discount rates, as well as migration curves for developed technology. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. Actual results could differ from these estimates and assumptions, and these differences could be material to the condensed consolidated financial statements.
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, disbursement prefunding, restricted cash, and customer funds receivable. The Company maintains cash and cash equivalents and restricted cash balances that may exceed the insured limits by the Federal Deposit Insurance Corporation. In addition, the Company funds its international operations using accounts with institutions in the major countries where its subsidiaries operate. The Company also prefunds amounts which are held by its disbursement partners, which are typically located in India, Mexico, and the Philippines. The Company has not experienced any significant losses on its deposits of cash and cash equivalents, disbursement prefunding, restricted cash, or customer funds receivable in the three months ended March 31, 2024 and 2023.</span></div>
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
51700000 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
34600000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1124000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1108000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1250000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
833000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
824000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
553000 usd
CY2024Q1 rely Revenue From Contract With Customer Sales Incentive
RevenueFromContractWithCustomerSalesIncentive
15397000 usd
CY2023Q1 rely Revenue From Contract With Customer Sales Incentive
RevenueFromContractWithCustomerSalesIncentive
11782000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269118000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203865000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22728000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11122000 usd
CY2024Q1 rely Payment Card Receivable Current
PaymentCardReceivableCurrent
8258000 usd
CY2023Q4 rely Payment Card Receivable Current
PaymentCardReceivableCurrent
15599000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4390000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2813000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4025000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2190000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
774000 usd
CY2024Q1 rely Employee Loan Receivable Current
EmployeeLoanReceivableCurrent
2038000 usd
CY2023Q4 rely Employee Loan Receivable Current
EmployeeLoanReceivableCurrent
1518000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1160000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1317000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44789000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33143000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47520000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42440000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28185000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26430000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19335000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16010000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2500000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1800000 usd
CY2024Q1 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
529000 usd
CY2023Q1 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
902000 usd
CY2024Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
587000 usd
CY2023Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
351000 usd
CY2024Q1 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
3973000 usd
CY2023Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized After Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
4031000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
200000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1200000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1200000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21500000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6073000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15427000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21500000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4858000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16642000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3643000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4858000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4525000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2401000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15427000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1200000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
50300000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
49400000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-21080000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-28314000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189848799 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189848799 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175113904 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175113904 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33215837 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39460403 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 rely Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10801396 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.46
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M13D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
161603000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
819904 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.05
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14413000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
74084 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.54
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9907408 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.56
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M9D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
160301000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8193954 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.40
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M7D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
142117000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9863138 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.58
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M13D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
159412000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2258000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2172000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14413000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
19007000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34088000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29234000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
800000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
800000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
792000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
792000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
78000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
792000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
870000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.050
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.013
CY2024Q1 rely Trade Settlement Liability
TradeSettlementLiability
67160000 usd
CY2023Q4 rely Trade Settlement Liability
TradeSettlementLiability
58950000 usd
CY2024Q1 rely Accrued Transaction Expense
AccruedTransactionExpense
20634000 usd
CY2023Q4 rely Accrued Transaction Expense
AccruedTransactionExpense
18500000 usd
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
16286000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
13633000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13166000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12990000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10582000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10251000 usd
CY2024Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
8739000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
9259000 usd
CY2024Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
3388000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
3359000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14037000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15295000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
155080000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145802000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
602000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
341000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
910000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
124000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2214000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5414000 usd
CY2024Q1 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
47000 usd
CY2023Q1 rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
149000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1487000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
541000 usd
CY2024Q1 rely Stock Issued Acquisition Consideration
StockIssuedAcquisitionConsideration
0 usd
CY2023Q1 rely Stock Issued Acquisition Consideration
StockIssuedAcquisitionConsideration
6635000 usd
CY2024Q1 rely Issuance Of Unvested Common Stock Subject To Service Based Vesting Conditions In Connection With Acquisition
IssuanceOfUnvestedCommonStockSubjectToServiceBasedVestingConditionsInConnectionWithAcquisition
0 usd
CY2023Q1 rely Issuance Of Unvested Common Stock Subject To Service Based Vesting Conditions In Connection With Acquisition
IssuanceOfUnvestedCommonStockSubjectToServiceBasedVestingConditionsInConnectionWithAcquisition
581000 usd
CY2024Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
0 usd
CY2023Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
11899000 usd
CY2024Q1 rely Business Combination Consideration Transferred Pre Existing Receivable Settlement
BusinessCombinationConsiderationTransferredPreExistingReceivableSettlement
0 usd
CY2023Q1 rely Business Combination Consideration Transferred Pre Existing Receivable Settlement
BusinessCombinationConsiderationTransferredPreExistingReceivableSettlement
2401000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001782170-24-000122-index-headers.html Edgar Link pending
0001782170-24-000122-index.html Edgar Link pending
0001782170-24-000122.txt Edgar Link pending
0001782170-24-000122-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rely-20240331.htm Edgar Link pending
rely-20240331.xsd Edgar Link pending
rely1q24-exhibit311.htm Edgar Link pending
rely1q24-exhibit312.htm Edgar Link pending
rely1q24-exhibit321.htm Edgar Link pending
rely1q24-exhibit322.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rely-20240331_def.xml Edgar Link unprocessable
rely-20240331_lab.xml Edgar Link unprocessable
rely-20240331_pre.xml Edgar Link unprocessable
rely-20240331_htm.xml Edgar Link completed
rely-20240331_cal.xml Edgar Link unprocessable